<p>Clinical and Microbiological Characteristics of Community-Onset Carbapenem-Resistant Enterobacteriaceae Isolates</p>-Reference-Cited by-同舟云学术

Clinical and Microbiological Characteristics of Community-Onset Carbapenem-Resistant Enterobacteriaceae Isolates

Published:2020-09 Issue: Volume:Volume 13 Page:3131-3143
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Hu Hangbin^ORCID,Mao Jinchao,Chen Yiyi,Wang Jie,Zhang Piaopiao,Jiang Yan,Yang Qing^ORCID,Yu Yunsong,Qu Tingting

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference26 articles.

1. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections

2. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control–CORRIGENDUM

3. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States.2019:148. Available from: www.cdc.gov/DrugResistance/Biggest-Threats.html. Accessed September 1, 2020.

4. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcontinental Dissemination of Enterobacterales Harboring bla_NDM-1 in Retail Frozen Shrimp;Foodborne Pathogens and Disease;2024-04-02

2. Identification and Genomic Analyses of a Multidrug Resistant Avian Pathogenic Escherichia coli Coharboring mcr-1, blaTEM-176 and blaCTX-M-14 Genes;Transboundary and Emerging Diseases;2024-02-16

3. Reviewing novel treatment options for carbapenem-resistant Enterobacterales;Expert Review of Anti-infective Therapy;2024-01-10

4. Carbapenemase-producing Klebsiella pneumoniae in community settings: a cross-sectional study in Belgrade, Serbia;Future Microbiology;2023-05

5. A Seven-Year Microbiological and Molecular Study of Bacteremias Due to Carbapenemase-Producing Klebsiella Pneumoniae: An Interrupted Time-Series Analysis of Changes in the Carbapenemase Gene’s Distribution after Introduction of Ceftazidime/Avibactam;Antibiotics;2022-10-14